Table 1 Patient characteristics
Variables | Number of cases | Percentage(%) |
|---|---|---|
Follow-up(months) | Â | Â |
Median(range) | 31(7–103) |  |
Age(years) | Â | Â |
Median(range) | 59(22–82) |  |
Pretreatment albumin | Â | Â |
≥35 g/L | 173 | 71.2 |
<35 g/L | 70 | 28.8 |
Pretreatment CEA a | Â | Â |
≤10 ng/ml | 186 | 76.5 |
>10 ng/ml | 57 | 23.5 |
Differentiation | Â | Â |
High | 24 | 9.9 |
Middle | 198 | 81.5 |
Low | 21 | 8.6 |
Sex | Â | Â |
Male | 134 | 55.1 |
Female | 109 | 44.9 |
Age | Â | Â |
≤49 years | 56 | 23.0 |
50-60 yeas | 72 | 29.6 |
>60 years | 115 | 47.3 |
am | Â | Â |
Rectum | 111 | 45.7 |
Left colon cancer | 77 | 31.7 |
Right colon cancer | 55 | 22.6 |
Stage | Â | Â |
II | 140 | 57.6 |
III | 103 | 42.4 |
Baseline neutrophil counts(×10 9 /L) |  |  |
Mean(± SD) | 4.27 ± 1.49 |  |
Baseline lymphocyte counts(×10 9 /L) |  |  |
Mean(± SD) | 1.88 ± 0.59 |  |
Chemotherapy-associated neutrophil counts | Â | Â |
Neutrophil counts ≥ 1.5 × 109/L | 153 | 63.0 |
Neutropenia < 1.5 × 109/L | 90 | 37.0 |
Chemotherapy-associated lymphocyte counts | Â | Â |
Lymphocyte counts ≥ 1.0 × 109/L | 139 | 57.2 |
Lymphopenia < 1.0 × 109/L | 104 | 42.8 |